Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	MHC class Ib protein binding	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4	1.27e-05	16	188	4	GO:0023029
GeneOntologyMolecularFunction	MHC class Ib receptor activity	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4	2.64e-05	19	188	4	GO:0032394
GeneOntologyMolecularFunction	phosphatidylcholine floppase activity	ABCA1 ATP8B1 ABCA7	4.44e-05	8	188	3	GO:0090554
GeneOntologyMolecularFunction	phosphatidylserine floppase activity	ABCA1 ATP8B1 ABCA7	6.62e-05	9	188	3	GO:0090556
GeneOntologyMolecularFunction	apolipoprotein A-I receptor activity	ABCA1 ABCA7	8.82e-05	2	188	2	GO:0034188
GeneOntologyMolecularFunction	phosphoenolpyruvate carboxykinase activity	PCK1 PCK2	8.82e-05	2	188	2	GO:0004611
GeneOntologyMolecularFunction	phosphoenolpyruvate carboxykinase (GTP) activity	PCK1 PCK2	8.82e-05	2	188	2	GO:0004613
GeneOntologyMolecularFunction	ATPase-coupled intramembrane lipid transporter activity	ABCA1 ABCA4 ATP8B1 ABCA7	1.31e-04	28	188	4	GO:0140326
GeneOntologyMolecularFunction	apolipoprotein receptor activity	ABCA1 ABCA7	2.63e-04	3	188	2	GO:0030226
GeneOntologyMolecularFunction	phosphoglucomutase activity	PGM1 PGM5	2.63e-04	3	188	2	GO:0004614
GeneOntologyMolecularFunction	floppase activity	ABCA1 ATP8B1 ABCA7	4.20e-04	16	188	3	GO:0140328
GeneOntologyMolecularFunction	phosphatidylcholine transporter activity	ABCA1 ATP8B1 ABCA7	8.32e-04	20	188	3	GO:0008525
GeneOntologyMolecularFunction	clathrin adaptor activity	AP2A1 AP2A2 HIP1R	1.11e-03	22	188	3	GO:0035615
GeneOntologyBiologicalProcess	propionate metabolic process	ACSS2 PCK1 PCK2	7.24e-06	5	187	3	GO:0019541
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	ABCA4 IQGAP2 TICAM1 CLIP1 ABCA7 MFF TYR AP2A1 AP2A2 VPS13A PKD1 DISP3 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 NOS3 PML DNAJC13 ANKFY1 DSC1 SH3GL1 HIP1R SCAMP2 RAB44 NECAP2 GGA1 PCDH7	1.85e-05	1307	189	28	GO:0030659
GeneOntologyCellularComponent	vesicle membrane	ABCA4 IQGAP2 TICAM1 CLIP1 ABCA7 MFF TYR AP2A1 AP2A2 VPS13A PKD1 DISP3 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 NOS3 PML DNAJC13 ANKFY1 DSC1 SH3GL1 HIP1R SCAMP2 RAB44 NECAP2 GGA1 PCDH7	2.37e-05	1325	189	28	GO:0012506
GeneOntologyCellularComponent	early endosome membrane	ABCA7 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 PML DNAJC13 SH3GL1 GGA1	1.39e-04	212	189	9	GO:0031901
GeneOntologyCellularComponent	endosome membrane	TICAM1 ABCA7 AP2A1 AP2A2 VPS13A KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 PML DNAJC13 ANKFY1 SH3GL1 SCAMP2 GGA1	3.95e-04	602	189	15	GO:0010008
MousePheno	hearing/vestibular/ear phenotype	IQGAP2 ASIC2 NAGLU KLHDC7B ATP8B1 ISL1 ADGRV1 TYR PCYOX1L PAX8 PRRC2C RNF10 FGF9 HES1 PPIP5K2 FOXC2 PLIN4 HSPG2 SCAMP2 POU4F3 DCHS1 GGA1 PADI3 OTOG	1.31e-05	905	142	24	MP:0005377
Domain	ig	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 HSPG2 OBSL1 KIR2DL5A	3.29e-06	190	186	11	PF00047
Domain	Immunoglobulin	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 HSPG2 OBSL1 KIR2DL5A	3.29e-06	190	186	11	IPR013151
Domain	Alpha_adaptinC2	AP2A1 AP2A2 GGA1	7.81e-05	9	186	3	PF02883
Domain	Clathrin_a/b/g-adaptin_app_Ig	AP2A1 AP2A2 GGA1	7.81e-05	9	186	3	IPR008152
Domain	Alpha_adaptinC2	AP2A1 AP2A2 GGA1	7.81e-05	9	186	3	SM00809
Domain	PEP_carboxykin_GTP_CS	PCK1 PCK2	9.86e-05	2	186	2	IPR018091
Domain	PEPCK	PCK1 PCK2	9.86e-05	2	186	2	PF00821
Domain	PEP_carboxykinase_GTP	PCK1 PCK2	9.86e-05	2	186	2	IPR008209
Domain	PEPCK_GTP	PCK1 PCK2	9.86e-05	2	186	2	PS00505
Domain	-	AP2A1 AP2A2	9.86e-05	2	186	2	2.60.40.1030
Domain	PEP_carboxykinase_N	PCK1 PCK2	9.86e-05	2	186	2	IPR008210
Domain	PEP_carboxykinase_C	PCK1 PCK2	9.86e-05	2	186	2	IPR013035
Domain	Clathrin_a-adaptin_app_Ig-like	AP2A1 AP2A2	9.86e-05	2	186	2	IPR013038
Domain	-	PCK1 PCK2	9.86e-05	2	186	2	3.90.228.20
Domain	AP2_complex_asu	AP2A1 AP2A2	9.86e-05	2	186	2	IPR017104
Domain	Clathrin_a-adaptin_app_sub_C	AP2A1 AP2A2	9.86e-05	2	186	2	IPR003164
Domain	-	PCK1 PCK2	9.86e-05	2	186	2	3.40.449.10
Domain	Alpha_adaptin_C	AP2A1 AP2A2	9.86e-05	2	186	2	PF02296
Domain	CADHERIN_1	CLSTN3 CDHR2 DSC1 PCDHGA4 DCHS1 PCDH7 PCDH8	1.38e-04	113	186	7	PS00232
Domain	Cadherin	CLSTN3 CDHR2 DSC1 PCDHGA4 DCHS1 PCDH7 PCDH8	1.38e-04	113	186	7	PF00028
Domain	CADHERIN_2	CLSTN3 CDHR2 DSC1 PCDHGA4 DCHS1 PCDH7 PCDH8	1.46e-04	114	186	7	PS50268
Domain	-	CLSTN3 CDHR2 DSC1 PCDHGA4 DCHS1 PCDH7 PCDH8	1.46e-04	114	186	7	2.60.40.60
Domain	Hist_deacetyl	HDAC9 HDAC3 HDAC5	1.51e-04	11	186	3	PF00850
Domain	-	HDAC9 HDAC3 HDAC5	1.51e-04	11	186	3	3.40.800.20
Domain	His_deacetylse_dom	HDAC9 HDAC3 HDAC5	1.51e-04	11	186	3	IPR023801
Domain	His_deacetylse	HDAC9 HDAC3 HDAC5	1.51e-04	11	186	3	IPR000286
Domain	CA	CLSTN3 CDHR2 DSC1 PCDHGA4 DCHS1 PCDH7 PCDH8	1.54e-04	115	186	7	SM00112
Domain	Cadherin-like	CLSTN3 CDHR2 DSC1 PCDHGA4 DCHS1 PCDH7 PCDH8	1.62e-04	116	186	7	IPR015919
Domain	Cadherin	CLSTN3 CDHR2 DSC1 PCDHGA4 DCHS1 PCDH7 PCDH8	1.80e-04	118	186	7	IPR002126
Domain	ABC_A	ABCA1 ABCA4 ABCA7	2.00e-04	12	186	3	IPR026082
Domain	Coatomer/clathrin_app_Ig-like	AP2A1 AP2A2 GGA1	2.00e-04	12	186	3	IPR013041
Domain	HDAC4_Gln	HDAC9 HDAC5	2.94e-04	3	186	2	PF12203
Domain	DUF3446	EGR1 EGR2	2.94e-04	3	186	2	PF11928
Domain	Hist_deacetylase_Gln_rich_N	HDAC9 HDAC5	2.94e-04	3	186	2	IPR024643
Domain	DUF3446	EGR1 EGR2	2.94e-04	3	186	2	IPR021849
Domain	IG	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 HSPG2 TAPBPL OBSL1 KIR2DL5A IL1RL1	3.17e-04	421	186	13	SM00409
Domain	Ig_sub	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 HSPG2 TAPBPL OBSL1 KIR2DL5A IL1RL1	3.17e-04	421	186	13	IPR003599
Domain	-	KIR2DS2 CMYA5 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 PLXNB1 HSPG2 FLNC TAPBPL OBSL1 MST1R KIR2DL5A IL1RL1	3.52e-04	663	186	17	2.60.40.10
Domain	-	CLSTN3 ADGRV1 SVEP1 HSPG2 LAMA3 LGALS4	3.75e-04	95	186	6	2.60.120.200
Domain	PGM_PMM_III	PGM1 PGM5	5.84e-04	4	186	2	PF02880
Domain	A-D-PHexomutase_CS	PGM1 PGM5	5.84e-04	4	186	2	IPR016066
Domain	DUF1908	MAST4 MAST1	5.84e-04	4	186	2	PF08926
Domain	MA_Ser/Thr_Kinase_dom	MAST4 MAST1	5.84e-04	4	186	2	IPR015022
Domain	Clathrin_a/coatomer_app_sub_C	AP2A1 AP2A2	5.84e-04	4	186	2	IPR015873
Domain	A-D-PHexomutase_a/b/a-III	PGM1 PGM5	5.84e-04	4	186	2	IPR005846
Domain	Histone_deAcase_II_euk	HDAC9 HDAC5	5.84e-04	4	186	2	IPR017320
Domain	-	AP2A1 AP2A2	5.84e-04	4	186	2	3.30.310.30
Domain	MAST_pre-PK_dom	MAST4 MAST1	5.84e-04	4	186	2	IPR023142
Domain	-	MAST4 MAST1	5.84e-04	4	186	2	1.20.1480.20
Domain	Ig-like_fold	KIR2DS2 CMYA5 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 PLXNB1 HSPG2 FLNC TAPBPL OBSL1 MST1R KIR2DL5A IL1RL1	7.15e-04	706	186	17	IPR013783
Domain	Cadherin_CS	CDHR2 DSC1 PCDHGA4 DCHS1 PCDH7 PCDH8	7.80e-04	109	186	6	IPR020894
Domain	PGM_PMM	PGM1 PGM5	9.67e-04	5	186	2	PS00710
Domain	PGM_PMM_II	PGM1 PGM5	9.67e-04	5	186	2	PF02879
Domain	PGM_PMM_I	PGM1 PGM5	9.67e-04	5	186	2	PF02878
Domain	PGM_PMM_IV	PGM1 PGM5	9.67e-04	5	186	2	PF00408
Domain	-	PGM1 PGM5	9.67e-04	5	186	2	3.40.120.10
Domain	A-D-PHexomutase_a/b/a-I/II/III	PGM1 PGM5	9.67e-04	5	186	2	IPR016055
Domain	A-D-PHexomutase_a/b/a-I	PGM1 PGM5	9.67e-04	5	186	2	IPR005844
Domain	A-D-PHexomutase_a/b/a-II	PGM1 PGM5	9.67e-04	5	186	2	IPR005845
Domain	A-D-PHexomutase_C	PGM1 PGM5	9.67e-04	5	186	2	IPR005843
Domain	Alpha-D-phosphohexomutase_SF	PGM1 PGM5	9.67e-04	5	186	2	IPR005841
Domain	-	PGM1 PGM5	9.67e-04	5	186	2	3.30.310.50
Domain	IG_LIKE	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 HSPG2 TAPBPL OBSL1 KIR2DL5A IL1RL1	1.32e-03	491	186	13	PS50835
Domain	Acid_Pase_AS	PPIP5K2 ACP4	1.44e-03	6	186	2	IPR033379
Domain	ConA-like_dom	CLSTN3 ADGRV1 CMYA5 SVEP1 HSPG2 RANBP9 LAMA3 LGALS4	1.61e-03	219	186	8	IPR013320
Domain	Ig-like_dom	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 HSPG2 TAPBPL OBSL1 KIR2DL5A IL1RL1	1.63e-03	503	186	13	IPR007110
Domain	ENaC	ASIC2 ASIC1	2.00e-03	7	186	2	IPR004724
Domain	HIS_ACID_PHOSPHAT_2	PPIP5K2 ACP4	2.00e-03	7	186	2	PS00778
Domain	HIS_ACID_PHOSPHAT_1	PPIP5K2 ACP4	2.00e-03	7	186	2	PS00616
Domain	His_Pase_clade-2	PPIP5K2 ACP4	2.66e-03	8	186	2	IPR000560
Domain	Coatomer/calthrin_app_sub_C	AP2A1 AP2A2	2.66e-03	8	186	2	IPR009028
Domain	GDA1_CD39_NTPase	ENTPD1 ENTPD2	2.66e-03	8	186	2	IPR000407
Domain	His_Phos_2	PPIP5K2 ACP4	2.66e-03	8	186	2	PF00328
Domain	LAMININ_IVA	HSPG2 LAMA3	2.66e-03	8	186	2	PS51115
Domain	Laminin_B	HSPG2 LAMA3	2.66e-03	8	186	2	PF00052
Domain	GDA1_CD39	ENTPD1 ENTPD2	2.66e-03	8	186	2	PF01150
Domain	GDA1_CD39_NTPASE	ENTPD1 ENTPD2	2.66e-03	8	186	2	PS01238
Domain	LamB	HSPG2 LAMA3	2.66e-03	8	186	2	SM00281
Domain	Na+channel_ASC_CS	ASIC2 ASIC1	2.66e-03	8	186	2	IPR020903
Domain	Laminin_IV	HSPG2 LAMA3	2.66e-03	8	186	2	IPR000034
Pathway	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	1.94e-06	88	135	8	M16004
Pathway	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	5.09e-05	137	135	8	M5669
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	1.79e-19	16	194	10	16403292
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.34e-19	17	194	10	20878400
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.34e-19	17	194	10	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.34e-19	17	194	10	19761533
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.34e-19	17	194	10	20650299
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.34e-19	17	194	10	19218127
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	9.40e-19	12	194	9	20371502
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	9.71e-19	18	194	10	20200544
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	3.04e-18	13	194	9	19120281
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.06e-18	20	194	10	20193031
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	8.47e-18	14	194	9	19875891
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	8.47e-18	14	194	9	19489269
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	8.47e-18	14	194	9	15896204
Pubmed	Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).	KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	1.41e-17	22	194	10	20492596
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	2.11e-17	15	194	9	17498266
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	2.11e-17	15	194	9	20082646
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	2.11e-17	15	194	9	20356536
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	2.11e-17	15	194	9	19926642
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	2.11e-17	15	194	9	20643584
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	2.11e-17	15	194	9	19326408
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.80e-17	16	194	9	19897003
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.80e-17	16	194	9	19309280
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.80e-17	16	194	9	20652381
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.80e-17	16	194	9	17868255
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.80e-17	16	194	9	20331834
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.80e-17	16	194	9	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.80e-17	16	194	9	20670355
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.80e-17	16	194	9	18668235
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.80e-17	16	194	9	19527230
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.80e-17	16	194	9	19279038
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.80e-17	16	194	9	18643961
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	4.80e-17	16	194	9	20210919
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	1.01e-16	17	194	9	19968064
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	1.01e-16	17	194	9	20483367
Pubmed	The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	1.01e-16	17	194	9	20173784
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	1.01e-16	17	194	9	20173792
Pubmed	KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	1.01e-16	17	194	9	19169284
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	1.32e-16	11	194	8	19664392
Pubmed	Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS4	1.51e-16	7	194	7	11169255
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	2.02e-16	18	194	9	20580654
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	2.02e-16	18	194	9	20519398
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	2.02e-16	18	194	9	19846535
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	2.02e-16	18	194	9	19630074
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	2.02e-16	18	194	9	19046302
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	3.82e-16	19	194	9	20600442
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	3.82e-16	19	194	9	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	3.82e-16	19	194	9	18778326
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	3.82e-16	19	194	9	18848853
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	3.94e-16	12	194	8	19936734
Pubmed	HLA and KIR frequencies in Sicilian Centenarians.	KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	6.91e-16	20	194	9	20426625
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	1.02e-15	13	194	8	18687225
Pubmed	NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4	1.20e-15	8	194	7	18681957
Pubmed	Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	1.20e-15	21	194	9	19861144
Pubmed	Multiple sclerosis associates with LILRA3 deletion in Spanish patients.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	2.37e-15	14	194	8	19421224
Pubmed	Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.	KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	3.75e-15	35	194	10	19683555
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	5.04e-15	15	194	8	19850842
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	5.04e-15	15	194	8	20207982
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	5.04e-15	15	194	8	19493232
Pubmed	Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3	1.78e-14	10	194	7	12559621
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	1.89e-14	17	194	8	19032228
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS3 KIR2DS4 KIR2DL5A	3.38e-14	18	194	8	20210918
Pubmed	Immunogenetic characteristics of patients with autoimmune gastritis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	3.94e-14	29	194	9	20082482
Pubmed	Natural killer cells and immune surveillance.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR2DL5A	4.88e-14	11	194	7	18830515
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4	1.17e-13	12	194	7	19181658
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	1.17e-13	12	194	7	20137308
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4	2.51e-13	13	194	7	19934297
Pubmed	Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL4 KIR2DS1 KIR2DS4 KIR2DL5A	5.00e-13	14	194	7	18945962
Pubmed	KIR haplotype content at the allele level in 77 Northern Irish families.	KIR2DS2 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR2DL5A	7.73e-13	8	194	6	17200871
Pubmed	Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4	2.31e-12	9	194	6	7749980
Pubmed	Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	5.13e-12	5	194	5	18755860
Pubmed	Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4	5.13e-12	5	194	5	10424431
Pubmed	Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	5.13e-12	5	194	5	16112031
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR2DL5A	2.50e-11	12	194	6	17490516
Pubmed	Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3	3.06e-11	6	194	5	17882223
Pubmed	Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3	1.07e-10	7	194	5	9430220
Pubmed	Human diversity in killer cell inhibitory receptor genes.	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3	2.83e-10	8	194	5	9430221
Pubmed	A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4	2.83e-10	8	194	5	15730517
Pubmed	Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population.	KIR2DS2 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DL5A	6.35e-10	9	194	5	18074414
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4	6.35e-10	9	194	5	8662091
Pubmed	Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.	KIR2DS2 KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4	6.35e-10	9	194	5	18340360
Pubmed	Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	9.39e-10	4	194	4	26542066
Pubmed	Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.	KIR2DL5B KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS4	1.26e-09	10	194	5	21206914
Pubmed	KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4	4.67e-09	5	194	4	27893413
Pubmed	Analysis of candidate genes on chromosome 19 in coeliac disease: an association study of the KIR and LILR gene clusters.	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL5A	4.67e-09	5	194	4	12121272
Pubmed	In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4	4.67e-09	5	194	4	19410616
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DL5A	1.40e-08	6	194	4	20528243
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA8 NAGLU KDM3B EXOSC8 ZNF236 ABCA7 AP2A1 SUMF1 PKD1 DMWD TRAPPC9 ATMIN HSPG2 FLNC PUF60 GRK6 HIP1R TBC1D17 MST1R PPP1R15B ENTPD2 MBD5 GGA1 CEP170B	1.52e-08	1105	194	24	35748872
Pubmed	Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4	3.24e-08	7	194	4	12618911
Pubmed	Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS4	3.24e-08	7	194	4	14607943
Pubmed	Expression of a killer cell receptor-like gene in plastic regions of the central nervous system.	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4	3.24e-08	7	194	4	15748957
Pubmed	Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis.	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4	3.24e-08	7	194	4	26928464
Pubmed	Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community.	KIR2DS2 KIR2DL1 KIR2DS1	1.71e-07	3	194	3	29549293
Pubmed	The LRC haplotype project: a resource for killer immunoglobulin-like receptor-linked association studies.	KIR2DL2 KIR2DS1 KIR2DL5A	1.71e-07	3	194	3	17092261
Pubmed	Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3	1.71e-07	3	194	3	22960345
Pubmed	[Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].	KIR2DL1 KIR2DL2 KIR2DL3	1.71e-07	3	194	3	19549382
Pubmed	The extended human leukocyte receptor complex: diverse ways of modulating immune responses.	KIR2DL2 KIR2DS1 KIR2DL5A	1.71e-07	3	194	3	18759923
Pubmed	Killer immunoglobulin receptor genes and their HLA-C ligand are associated with Type 1 diabetes in an Eastern Indian population.	KIR2DL2 KIR2DL3 KIR2DS4	1.71e-07	3	194	3	26031759
Pubmed	Evaluation of the genetic diversity of KIR genes in patients with endometrial cancer.	KIR2DS2 KIR2DL2 KIR2DS4	1.71e-07	3	194	3	38387251
Pubmed	Promoter variants of KIR2DL5 add to diversity and may impact gene expression.	KIR2DL5B KIR2DS1 KIR2DL5A	1.71e-07	3	194	3	18461314
Pubmed	The effect of killer cell immunoglobulin-like receptor genotype on outcome of hematopoietic stem cell transplantation from matched sibling.	KIR2DS3 KIR2DS4 KIR2DL5A	1.71e-07	3	194	3	28993188
Interaction	KIR2DL2 interactions	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3	5.23e-06	13	191	4	int:KIR2DL2
Interaction	IRF2BP1 interactions	PAX8 PML SOX6 DNAJC13 HIP1R OBSL1 QPRT	1.18e-05	81	191	7	int:IRF2BP1
Interaction	PRG2 interactions	CLSTN3 NAGLU JMJD4 ITGA7 SUMF1 FOXF2 HSPG2 COL6A2 HYAL1 RANBP9 MST1R ENTPD2	1.86e-05	285	191	12	int:PRG2
Interaction	NFATC1 interactions	ISL1 HDAC3 NUP210 PML HDAC5 RANBP9 OBSL1 EGR1 EGR2	3.31e-05	168	191	9	int:NFATC1
Interaction	KIR2DS3 interactions	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3	3.36e-05	20	191	4	int:KIR2DS3
Interaction	FBXO2 interactions	CDHR2 NAGLU ADGRV1 RNF157 PCYOX1L ERAP2 SUMF1 NUP210 HSPG2 COL6A2 DNAJC13 B3GALNT2 LAMA3 TCTN2	3.97e-05	411	191	14	int:FBXO2
Cytoband	19q13.4	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 ACP4	5.69e-11	79	194	9	19q13.4
Cytoband	19p13.3	TICAM1 ABCA7 KIR2DL5B PLIN4 AMH SH3GL1 PRR22 KIR2DL5A	8.45e-06	237	194	8	19p13.3
Cytoband	3p21.3	EXOG UQCRC1 MST1R RBM6	1.17e-04	59	194	4	3p21.3
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS2 KIR2DL5B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DL5A	9.22e-18	18	128	10	620
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS4 MST1R THBD ENTPD1 KIR2DL5A	1.14e-04	394	128	11	471
GeneFamily	ATP binding cassette subfamily A	ABCA1 ABCA4 ABCA7	1.19e-04	14	128	3	805
GeneFamily	Cadherin related	CLSTN3 CDHR2 DCHS1	2.19e-04	17	128	3	24
GeneFamily	Histone deacetylases, class IIA	HDAC9 HDAC5	2.96e-04	4	128	2	992
GeneFamily	Acid sensing ion channel subunits	ASIC2 ASIC1	4.90e-04	5	128	2	290
GeneFamily	Non-clustered protocadherins	PCDH7 PCDH8	3.13e-03	12	128	2	21
Coexpression	KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DL5A	2.50e-09	49	192	8	M40909
Coexpression	CYCLIN_D1_UP.V1_UP	FCGBP KIAA1549L PKD1 KIR2DL3 DMWD HSPG2 GPT THBD EGR1	1.04e-05	187	192	9	M2654
Coexpression	GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP	ABCA4 IQGAP2 FGF9 KIR2DS3 COL6A2 GRK6 EGR1 KIR2DL5A ZMYM4	1.58e-05	197	192	9	M7264
Coexpression	GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP	DCDC2B STAT6 PIK3IP1 PRRC2C PPP1R3F HDAC5 B3GALNT2 SH3GL1 RBM6	1.71e-05	199	192	9	M3050
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL	CPNE2 CLSTN3 CMYA5 ERAP2 VPS13A FGF9 PRXL2C PLXNB1 SOX6 HSPG2 FLNC CAPG OBSL1 LAMA3 TBC1D17 THBD ENTPD2 KNDC1 MEDAG PCK1	2.58e-05	955	192	20	M45680
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	PDHB KDM3B EXOSC8 CLIP1 PGM1 STAT6 CUEDC1 ERAP2 NUP210 DXO DNAJC13 ANKFY1 OXR1 OBSL1 PUM2 PNISR ZNF7 THBD EGR1 ASMTL ENTPD1 CNOT1 ZMYM4	3.05e-05	1215	192	23	M41122
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	VWA8 MAST4 PAX8 PRRC2C SUMF1 VPS13A PNISR RBM6 MBD5	3.90e-05	221	192	9	M39222
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	VWA8 MAST4 PAX8 SUMF1 VPS13A SOX6 OXR1 MBD5	4.88e-05	176	192	8	M39223
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000	HDAC9 NPAS3 ISL1 KEAP1 ACSS2 RNF157 PGM5 FAP KIAA1549L DISP3 FGF9 PPIP5K2 RAD21 COL6A2 TAPBPL KIF26B CAPG PODXL2 TBC1D17 LGALS4 ZNF7 EGR1 EGR2 ENTPD1 KNDC1 CEP170B PCK2	4.32e-08	978	177	27	Facebase_RNAseq_e10.5_Mandibular Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000	HDAC9 CLSTN3 NPAS3 ADGRV1 ACSS2 RNF157 PGM5 FAP KIAA1549L PAX8 NUP210 FGF9 HES1 COL6A2 IRS4 TAPBPL KIF26B CAPG PODXL2 TBC1D17 LGALS4 QPRT ENTPD1 FAM169A CEP170B	5.84e-07	976	177	25	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_200	HDAC9 ISL1 FOXF2 IRS4 KIF26B	3.20e-06	28	177	5	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_200
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000	HDAC9 CLSTN3 NPAS3 ISL1 ADGRV1 ACSS2 RNF157 PGM5 FAP KIAA1549L FGF9 CACNA1A DXO COL6A2 TAPBPL KIF26B CAPG PODXL2 TBC1D17 LGALS4 QPRT ENTPD1 CEP170B	5.91e-06	967	177	23	Facebase_RNAseq_e9.5_Maxillary Arch_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000	HDAC9 CLSTN3 NPAS3 ADGRV1 ACSS2 RNF157 PGM5 FAP KIAA1549L FGF9 CACNA1A COL6A2 IRS4 TAPBPL KIF26B CAPG PODXL2 PDCD2L TBC1D17 LGALS4 QPRT ENTPD1 CEP170B	6.43e-06	972	177	23	Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000	HDAC9 CLSTN3 ABCA1 NPAS3 ACSS2 RNF157 PGM5 FAP KIAA1549L FGF9 CACNA1A COL6A2 IRS4 TAPBPL KIF26B CAPG PODXL2 TBC1D17 LGALS4 ENTPD1 MAST1 CEP170B	1.91e-05	967	177	22	Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000	HDAC9 CLSTN3 NPAS3 ACSS2 RNF157 PGM5 FAP KIAA1549L PAX8 NUP210 FGF9 CACNA1A COL6A2 TAPBPL KIF26B CAPG PODXL2 TBC1D17 LGALS4 ENTPD1 MAST1 CEP170B	1.94e-05	968	177	22	Facebase_RNAseq_e9.5_Facial Mesenchyne_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_500	HDAC9 NPAS3 ISL1 FOXF2 IRS4 KIF26B	2.02e-05	67	177	6	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000	CLSTN3 NPAS3 ISL1 ADGRV1 ACSS2 PGM5 FAP KIAA1549L NUP210 EXOC6B FGF9 PLXNB1 COL6A2 IRS4 TAPBPL KIF26B SYAP1 TBC1D17 ZNF7 ENTPD1 MAST1 CEP170B	2.49e-05	984	177	22	Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#4	HDAC9 NPAS3 ISL1 ADGRV1 ACSS2 RNF157 KIAA1549L CACNA1A PODXL2 QPRT	2.61e-05	232	177	10	Facebase_RNAseq_e9.5_Maxillary Arch_1000_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000	SOX5 HDAC9 IQGAP2 NPAS3 ISL1 LARP4 CLIP1 RNF157 PGM5 ZNF469 AP2A2 NOPCHAP1 FOXF2 PUM2 HEATR1 ENTPD1 MEDAG PCDH7 PCDH8	4.96e-05	811	177	19	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000
CoexpressionAtlas	JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3	ATP8B1 SVEP1 FAP FOXF2 KIF26B PCDHGA4 EGR2 KIAA1755 GLIS1	6.00e-05	206	177	9	JC_fibro_500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500	CLSTN3 NPAS3 ACSS2 PGM5 FAP KIAA1549L FGF9 COL6A2 IRS4 TAPBPL KIF26B TBC1D17 ENTPD1 CEP170B	6.42e-05	489	177	14	Facebase_RNAseq_e8.5_Paraxial Mesoderm_500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2	NPAS3 ISL1 ADGRV1 ACSS2 KIAA1549L NUP210 PLXNB1 ZNF7 MAST1	6.96e-05	210	177	9	Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2
CoexpressionAtlas	Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4	CPNE2 ABCA1 PGM5 HES1 NOS3 FOXC2 HSPG2 HYAL1 ASAH2 THBD EGR1 DCHS1 PCDH7	1.08e-04	450	177	13	GSM777063_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5	KEAP1 PGM5 FAP DISP3 COL6A2 KIF26B TBC1D17 ZNF7 EGR1 EGR2 PCK2	1.10e-04	331	177	11	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#4	HDAC9 NPAS3 ACSS2 RNF157 KIAA1549L NUP210 CACNA1A PODXL2 MAST1	1.10e-04	223	177	9	Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K4
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#4_top-relative-expression-ranked_200	FOXC2 EGR1 EGR2 GPR176	1.23e-04	31	177	4	gudmap_developingKidney_e15.5_Cap mesenchyme_200_k4
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000	HDAC9 CLSTN3 ABCA1 NPAS3 ACSS2 RNF157 PGM5 FAP KIAA1549L FGF9 CACNA1A COL6A2 TAPBPL KIF26B CAPG PODXL2 TBC1D17 LGALS4 ENTPD1 CEP170B	1.71e-04	967	177	20	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3	CPNE2 SOX5 ABCA1 NPAS3 ISL1 ADGRV1 ACSS2 CLIP1 RNF157 ZSCAN29 KIAA1549L NUP210 PLXNB1 SOX6 CACNA1A HYAL1 PODXL2 QPRT MAST1	1.75e-04	893	177	19	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2	SOX5 HDAC9 ABCA1 VWA8 NPAS3 ISL1 ADGRV1 ACSS2 RNF157 ZSCAN29 KIAA1549L CACNA1A HDAC5 HYAL1 PODXL2 QPRT MAST1	1.78e-04	747	177	17	Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000	CLSTN3 NPAS3 ISL1 ADGRV1 ACSS2 PGM5 FAP KIAA1549L NUP210 FGF9 PLXNB1 COL6A2 IRS4 KIF26B TBC1D17 ZNF7 ENTPD1 FAM169A MAST1 CEP170B	1.85e-04	973	177	20	Facebase_RNAseq_e9.5_Olfactory Placode_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_200	FOXC2 KIF26B PCDH8	1.94e-04	14	177	3	gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	SOX5 NPAS3 ISL1 ADGRV1 LARP4 PGM5 ZSCAN29 KIAA1549L NUP210 VPS13A SOX6 CACNA1A KIF26B HYAL1 TBC1D17 ZNF7 QPRT FAM169A KNDC1 MAST1	2.12e-04	983	177	20	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_1000	HDAC9 IQGAP2 NPAS3 ISL1 FOXF2 IRS4 KIF26B	2.37e-04	147	177	7	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500	SOX5 NPAS3 ISL1 ADGRV1 KIAA1549L PAX8 NUP210 PLXNB1 SOX6 IRS4 HYAL1 QPRT MAST1	2.79e-04	496	177	13	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_100	ISL1 FOXF2 KIF26B	2.94e-04	16	177	3	gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k3
CoexpressionAtlas	Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4	CPNE2 ABCA1 PGM5 NOS3 FOXC2 HSPG2 HYAL1 ASAH2 THBD EGR1 DCHS1 PCDH7	3.29e-04	439	177	12	GSM777059_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	HDAC9 ABCA1 IQGAP2 NPAS3 ATP8B1 ISL1 PGM5 FAP VPS13A FOXF2 IRS4 KIF26B LAMA3 THBD ENTPD1 PCDH7 ZMYM4	4.28e-04	806	177	17	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5	HDAC9 ABCA1 VWA8 NPAS3 ADGRV1 ACSS2 RNF157 ZSCAN29 KIAA1549L CZIB CACNA1A HDAC5 HYAL1 PODXL2 QPRT MAST1	5.07e-04	743	177	16	Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000	NPAS3 PGM5 ZSCAN29 FAP KIAA1549L FGF9 NAPSA CACNA1A COL6A2 KIF26B HYAL1 PODXL2 SCAMP2 TBC1D17 EGR1 ENTPD1 GLIS1 SNTB1 CEP170B	5.08e-04	973	177	19	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_200	ISL1 FAP FOXF2 KIF26B EGR1 EGR2 ENTPD1	5.13e-04	167	177	7	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_200	HDAC9 IQGAP2 ISL1 FOXF2 IRS4 KIF26B THBD	5.71e-04	170	177	7	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_200	NPAS3 ISL1 FOXF2 PCDH8	5.79e-04	46	177	4	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_200
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SVEP1 FAP HSPG2 COL6A2 MST1R ENTPD2 MEDAG KIAA1755 PCDH7	1.40e-07	192	189	9	e4a7f2673f801b008ca67291db2fb2b9fd2955b8
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SVEP1 FAP HSPG2 COL6A2 MST1R ENTPD2 MEDAG KIAA1755 PCDH7	1.40e-07	192	189	9	8937a59f6bbe07f671bdabbd3707dc9c17a14cd9
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SVEP1 FAP HSPG2 COL6A2 MST1R ENTPD2 MEDAG KIAA1755 PCDH7	1.40e-07	192	189	9	ac1477433704573f95111eee6263b93668d2845e
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	IQGAP2 NPAS3 ADGRV1 MAST4 NUP210 HES1 SOX6 CAPG EGR1	1.75e-07	197	189	9	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	IQGAP2 NPAS3 ADGRV1 MAST4 NUP210 HES1 SOX6 CAPG EGR1	1.75e-07	197	189	9	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 CMYA5 ITGA7 PGM5 FLNC USP13 XIRP2 PCDH7	8.90e-07	176	189	8	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	SVEP1 FAP HSPG2 COL6A2 IQCH MEDAG KIAA1755 GPR176	9.29e-07	177	189	8	3d955ea938a1d2fb1b6d68d4997fd454bd632dfc
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ASIC2 NPAS3 PAX8 SOX6 OXR1 KIF26B GPR176 HYDIN	9.69e-07	178	189	8	544379f5a6145429762258d426b876bb36c112f5
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 ADGRV1 DISP3 KIF26B XIRP2 HYDIN UNC80 OTOG	1.24e-06	184	189	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 ADGRV1 DISP3 KIF26B XIRP2 HYDIN UNC80 OTOG	1.24e-06	184	189	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 ADGRV1 DISP3 KIF26B XIRP2 HYDIN UNC80 OTOG	1.24e-06	184	189	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SVEP1 FAP HSPG2 COL6A2 THBD EGR1 ENTPD2 MEDAG	1.52e-06	189	189	8	bc54ffd7bd1627a36747a80ce5139e4a69928400
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX5 DENND2A SVEP1 COL6A2 KIF26B KIAA1755 PCDH7 GPR176	1.58e-06	190	189	8	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SVEP1 FAP HSPG2 COL6A2 THBD EGR1 ENTPD2 MEDAG	1.58e-06	190	189	8	f3ca94a31a35eed5fecf3c4b8c957e1bc4150158
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SVEP1 FAP HSPG2 COL6A2 THBD EGR1 ENTPD2 MEDAG	1.58e-06	190	189	8	c2cd1eb674162ee40502c3380b7245c85079c7ce
ToppCell	droplet-Heart-nan-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CMYA5 COL6A2 OBSL1 XIRP2 ENTPD2 MEDAG KIAA1755 PCDH7	1.58e-06	190	189	8	96a92212ea3fb35fa3d0da495e504edc61c71c23
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-filiform\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC36 ISL1 FOXF2 SOX6 KIF26B RAB44 PCDH7 GLIS1	1.58e-06	190	189	8	8a53f4d3c9aca45b5826f53f7dcdfb8bc8280acb
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 IQGAP2 CMYA5 PAX8 SOX6 HIP1R ELF3 PCDH7	1.64e-06	191	189	8	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Vein\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HDAC9 ATP8B1 PGM5 KIAA1549L NOS3 HSPG2 THBD ENTPD1	1.71e-06	192	189	8	81baf1c4063469bb0c03a8602b40e387ba7b0dfb
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B1 SVEP1 FAP HSPG2 COL6A2 ENTPD2 MEDAG KIAA1755	1.71e-06	192	189	8	840a34c1b82d218be999ab5e1bcafd6370d7a4b1
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B1 SVEP1 FAP HSPG2 COL6A2 ENTPD2 MEDAG KIAA1755	1.71e-06	192	189	8	671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Vein\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HDAC9 CLSTN3 PGM5 KIAA1549L NOS3 HSPG2 THBD ENTPD1	1.71e-06	192	189	8	717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HDAC9 ATP8B1 PGM5 KIAA1549L NOS3 HSPG2 THBD ENTPD1	1.78e-06	193	189	8	7261c1ce30c796b61c6ec58e64a051baa24732ff
ToppCell	Brain_organoid-organoid_Velasco_nature-6_mon\|organoid_Velasco_nature / Sample Type, Dataset, Time_group, and Cell type.	ABCA1 NPAS3 ADGRV1 ITGA7 HES1 SOX6 EGR1 QPRT	2.15e-06	198	189	8	a6f65bb0845d8f64f5c7edb00cee3ca5adb1a373
ToppCell	Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CMYA5 ZNF469 COL6A2 FLNC PCDHGA4 FSCN3 MEDAG KIAA1755	2.15e-06	198	189	8	e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30
ToppCell	Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CMYA5 ZNF469 COL6A2 FLNC PCDHGA4 FSCN3 MEDAG KIAA1755	2.15e-06	198	189	8	0cd930e374c2c48d1991b51c025f9801b22ecee7
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Vein\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	HDAC9 CLSTN3 ATP8B1 PGM5 MAST4 KIAA1549L NOS3 ENTPD1	2.23e-06	199	189	8	cfb624c7728046fc7f3ef071f57e4d7b013f3fef
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	HDAC9 CLSTN3 PGM5 KIAA1549L NOS3 HSPG2 THBD ENTPD1	2.32e-06	200	189	8	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	ASIC2 ITGA7 SVEP1 FAP COL6A2 FLNC MEDAG GPR176	2.32e-06	200	189	8	cdaf462b1db29dab61038eeab5ddd3eef3386763
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX5 DENND2A ASIC2 ADGRB1 ITGA7 FOXF2 COL6A2	4.74e-06	156	189	7	6365b69ede98bc866e996bc52736b00401aacf6f
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 PIK3IP1 B3GNT6 HES1 RAB44 MST1R UNC80	9.70e-06	174	189	7	a9f34d1237f335d27c5560ff514368f4709f9144
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE2 IQGAP2 ASIC1 KLHDC7B SVEP1 LAMA3 PCDH8	1.01e-05	175	189	7	e78bf0c33a741bb97e987e41ac33da9e623a08ec
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 PIK3IP1 B3GNT6 HES1 RAB44 MST1R UNC80	1.04e-05	176	189	7	d43d9e86c4d4fa1e88fbf2b899ac7143717aac90
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE2 IQGAP2 ASIC1 SVEP1 DEFB105A LAMA3 PCDH8	1.08e-05	177	189	7	d7976eac7e27044f6a859cc0c3398d08576e8c01
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAP ZNF469 KIAA1549L FOXF2 COL6A2 KIF26B GPR176	1.21e-05	180	189	7	935c091bbcd6d10b81dc4731779e5bd98205c99f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 DENND2A SVEP1 FAP COL6A2 GPR176 GLIS1	1.21e-05	180	189	7	280ff5c8f292be1b88120db5ff1788b750644856
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 DENND2A SVEP1 FAP COL6A2 GPR176 GLIS1	1.21e-05	180	189	7	fdbd7c22044d9328a1e06e2f9a4451529d1df767
ToppCell	renal_papilla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 ABCA4 HSPG2 KIF26B FAM169A ELF3 PCDH7	1.21e-05	180	189	7	49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4
ToppCell	5'-Airway_Nasal-Mesenchymal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAP ZNF469 KIAA1549L FOXF2 COL6A2 KIF26B GPR176	1.21e-05	180	189	7	3dd384b7f3d9582b8fec9fe05100e466e6218b76
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SVEP1 FAP ZNF469 COL6A2 EGR1 ENTPD2 KIAA1755	1.25e-05	181	189	7	3462aa1c08fbaf613b6278ab2c7a5a0940bf537d
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SVEP1 FAP ZNF469 COL6A2 EGR1 ENTPD2 KIAA1755	1.25e-05	181	189	7	6730e249cac55ae892cc567d9211615882f3dab4
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	HDAC9 CMYA5 MAST4 EXOC6B FLNC USP13 XIRP2	1.30e-05	182	189	7	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DENND2A SVEP1 HSPG2 COL6A2 EGR1 MEDAG KIAA1755	1.30e-05	182	189	7	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	HDAC9 CACNA1A B3GALNT2 LAMA3 ENTPD1 PCDH7 GPR176	1.35e-05	183	189	7	818fd886e0188091310825f9145fa53328f2c979
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SOX5 ADGRV1 ACSS2 MAST4 NAPSA LAMA3 ELF3	1.35e-05	183	189	7	6847c1252d6bb105524f812658112517fd351eab
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAP ZNF469 KIAA1549L FOXF2 COL6A2 KIF26B GPR176	1.35e-05	183	189	7	803376f5260de83c48d4f7301278d078a32b3e6e
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAP ZNF469 KIAA1549L FOXF2 COL6A2 KIF26B GPR176	1.35e-05	183	189	7	6d98973098c6d20c5305bce6a83a549a7d8dbfba
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAP ZNF469 KIAA1549L FOXF2 COL6A2 KIF26B GPR176	1.35e-05	183	189	7	cc7f5a17b40e8d901885174922e5fa8877643071
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SUMF1 CFAP70 HSPG2 COL6A2 FLNC ENTPD2 MEDAG	1.35e-05	183	189	7	07ca2786e62eca9feecf5e54a11864a960f7641a
ToppCell	LA-11._Adipocyte\|World / Chamber and Cluster_Paper	SOX5 CLSTN3 ACSS2 RNF157 PLIN4 SNTB1 PCK1	1.35e-05	183	189	7	b177be283e1553fb1f69a346f1ba79ad00297fa2
ToppCell	droplet-Kidney-nan-21m-Mesenchymal-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EXOC6B FOXC2 COL6A2 HDAC5 OBSL1 ENTPD2 TCTN2	1.35e-05	183	189	7	ad7421623e4c0c5ba02eec56e9bdae43ebb88d90
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	HDAC9 CACNA1A B3GALNT2 LAMA3 ENTPD1 PCDH7 GPR176	1.35e-05	183	189	7	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	HDAC9 CMYA5 MAST4 EXOC6B FLNC XIRP2 PCDH7	1.39e-05	184	189	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 CMYA5 PGM5 EXOC6B FLNC XIRP2 PCDH7	1.44e-05	185	189	7	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 IQGAP2 NPAS3 ATP8B1 PGM5 PAX8 PCDH7	1.44e-05	185	189	7	d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	HDAC9 VWA8 CMYA5 MAST4 EXOC6B XIRP2 PCDH7	1.44e-05	185	189	7	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	moderate-Lymphoid-NK\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TYR FAP KIAA1549L COL6A2 DCHS1 MEDAG GPR176	1.44e-05	185	189	7	4979a787acbc9b4ca8defe91cc79b674e51af1bf
ToppCell	droplet-Bladder-nan-24m-Endothelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA7 B3GNT6 FAP NOS3 AMH THBD ENTPD1	1.44e-05	185	189	7	90caab8d9361a541c5d5121c97c3f1cdffeeae4a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAST4 PAX8 SOX6 OXR1 KIF26B HYDIN GLIS1	1.49e-05	186	189	7	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CDHR2 MAST4 PAX8 PLIN4 GPT KIAA1755 PCK1	1.49e-05	186	189	7	b1edc341d6684b347dc9e21b34f62f51d095d735
ToppCell	Control-Endothelial-Endothelial-Vein\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HDAC9 CLSTN3 PGM5 KIAA1549L HSPG2 THBD ENTPD1	1.49e-05	186	189	7	92092f11ecce22c14f244e42c499af0822977e6f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 DENND2A ASIC2 PAX8 OXR1 LAMA3 MST1R	1.55e-05	187	189	7	42a1267bfc27b4460b8409ada580a87c4385841c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 DENND2A ASIC2 PAX8 OXR1 LAMA3 MST1R	1.55e-05	187	189	7	64afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 DENND2A ASIC2 PAX8 OXR1 LAMA3 MST1R	1.55e-05	187	189	7	87b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FOXC2 HSPG2 COL6A2 ENTPD2 MEDAG KIAA1755 PCDH7	1.55e-05	187	189	7	ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	HDAC9 VWA8 CMYA5 MAST4 USP13 XIRP2 PCDH7	1.60e-05	188	189	7	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA4 NPAS3 PGM5 NOS3 FOXC2 FLNC THBD	1.66e-05	189	189	7	55a1776a4ce049959b3f13a43744c7314bc1f00a
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	CMYA5 MAST4 EXOC6B FLNC USP13 XIRP2 PCDH7	1.66e-05	189	189	7	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	Globus_pallidus-Endothelial\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	PGM5 STAT6 HES1 FOXF2 HSPG2 CAPG THBD	1.66e-05	189	189	7	ad7dc9d25edd68fb624380a082c389fe7d640e7d
ToppCell	droplet-Tongue-nan-3m-Epithelial-filiform\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC36 ISL1 FOXF2 SOX6 RAB44 PCDH7 GLIS1	1.71e-05	190	189	7	251e3a33041023bfc4b547c7eb68cfb8f421636f
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 CMYA5 ITGA7 PGM5 FLNC XIRP2 PCDH7	1.71e-05	190	189	7	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	Mesenchymal-airway_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	DENND2A FOXF2 COL6A2 FLNC KIF26B PCDH7 GPR176	1.71e-05	190	189	7	645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SOX5 ADGRV1 MAST4 SOX6 NAPSA LAMA3 ELF3	1.77e-05	191	189	7	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE2 ASIC1 NPAS3 SVEP1 LAMA3 PODXL2 PCDH8	1.77e-05	191	189	7	764c3a8829ae1253a0790744138266e81fc075ec
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAP ZNF469 COL6A2 ENTPD2 MEDAG KIAA1755 PCDH7	1.77e-05	191	189	7	4b50fdd310701251e64e16cd2d07ce03dbfd3e3e
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAP FOXC2 COL6A2 QPRT ENTPD2 MEDAG KIAA1755	1.77e-05	191	189	7	db4943dd19207663fb9e27f8940fa4b06a933625
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 SVEP1 FAP COL6A2 KIF26B KIAA1755 PCDH7	1.77e-05	191	189	7	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	facs-Heart-LV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B1 ITGA7 SVEP1 FAP COL6A2 ENTPD2 KIAA1755	1.77e-05	191	189	7	b7a57691a4742070cee640e285c1f4d0da95baf1
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLIP1 FAP PRRC2C EGR1 ENTPD2 MEDAG PCDH7	1.77e-05	191	189	7	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAP ZNF469 COL6A2 ENTPD2 MEDAG KIAA1755 PCDH7	1.77e-05	191	189	7	75d2197076a9dfc868e8baf95bd4c5e44f438e3e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 SVEP1 FAP COL6A2 KIF26B KIAA1755 PCDH7	1.77e-05	191	189	7	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HDAC9 PGM5 KIAA1549L NOS3 HSPG2 THBD ENTPD1	1.83e-05	192	189	7	52acaecd3703166f5ce3b328aff7c82bd142fee4
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAP PRRC2C COL6A2 EGR1 ENTPD2 MEDAG PCDH7	1.83e-05	192	189	7	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SVEP1 HSPG2 COL6A2 FLNC ENTPD2 MEDAG KIAA1755	1.83e-05	192	189	7	f9fb24457999dc9e751a099d7f995543b9330ad4
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MAST4 EXOC6B TRAPPC9 SOX6 OXR1 RBM6 MBD5	1.83e-05	192	189	7	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 ATP8B1 KIAA1549L NOS3 HSPG2 THBD ENTPD1	1.90e-05	193	189	7	0b328f725f6feba263783eaca60c142e80df90f3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 ATP8B1 KIAA1549L NOS3 HSPG2 ENTPD1 GPR176	1.90e-05	193	189	7	2e72309607902dabe3218888b22a77fe941f3570
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IQGAP2 CMYA5 PAX8 SOX6 HIP1R ELF3 PCDH7	1.96e-05	194	189	7	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A ASIC2 PAX8 OXR1 LAMA3 ELF3 HYDIN	1.96e-05	194	189	7	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IQGAP2 CMYA5 PAX8 SOX6 HIP1R ELF3 PCDH7	1.96e-05	194	189	7	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 COL6A2 FLNC PODXL2 ENTPD2 MEDAG KIAA1755	1.96e-05	194	189	7	5594f7437448cb4b37d2d100f44d30c4a367df26
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CPNE2 DENND2A NPAS3 IRS4 LAMA3 PCDH8	1.97e-05	130	189	6	56b9c3325e011f1dbaf9efc71bd6e1af4f96fda6
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-Goblet_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA4 ATP8B1 ACSS2 B3GNT6 FCGBP LGALS4 ELF3	2.03e-05	195	189	7	219c5d0cde7f6082755154f54db221413ec555cb
ToppCell	5'-GW_trimst-2-LargeIntestine\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	B3GNT6 FCGBP HES1 CAPG LGALS4 ELF3 PCK1	2.03e-05	195	189	7	1a4a5623fa0318ef388cc228c7060e0586a7acf9
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA4 ATP8B1 ACSS2 B3GNT6 FCGBP LGALS4 ELF3	2.03e-05	195	189	7	c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d
ToppCell	ASK452\|World / Donor, Lineage and Cell class of Lung cells from Dropseq	CLIP1 PRRC2C HES1 FLNC THBD MEDAG IL1RL1	2.03e-05	195	189	7	7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c
ToppCell	mLN-T_cell-gd_T\|T_cell / Region, Cell class and subclass	KIR2DL1 KIR2DL4 PLXNB1 KIF26B FSCN3 LGALS4 ENTPD1	2.09e-05	196	189	7	8f476408cd5a4ea9d25c763c66565343d7989b38
ToppCell	10x3'2.3-week_14-16-Mesenchymal_fibro-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	SOX5 FAP COL6A2 FLNC ENTPD2 MEDAG PCDH7	2.09e-05	196	189	7	fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HDAC9 DENND2A ITGA7 PGM5 COL6A2 ENTPD1 PCDH7	2.09e-05	196	189	7	9830fb3da7a60f65ad463e9054bb77c06b025e4d
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-goblet\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ATP8B1 ACSS2 B3GNT6 FCGBP LGALS4 EGR1 ELF3	2.09e-05	196	189	7	c2d17630f7bfc9e727de55e093c17fddac61b61f
Drug	Aa1	CRISP3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4	5.08e-07	83	192	8	CID009549188
Drug	D-Au	EXOG KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4	3.97e-06	77	192	7	CID000277822
Drug	ms-27	HDAC9 HDAC3 HDAC5	5.83e-06	5	192	3	CID016122504
Drug	0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A	DENND2A ABCA1 PAX8 DMWD TRAPPC9 PML MST1R ENTPD1 GGA1 PCDH7	7.74e-06	199	192	10	3966_UP
Drug	6-amidino-2-naphthol	ASIC2 ASIC1 AMH	1.16e-05	6	192	3	CID005490350
Disease	Phosphoenolpyruvate carboxykinase deficiency	PCK1 PCK2	3.91e-05	2	185	2	C0268194
Disease	acute kidney failure (biomarker_via_orthology)	HDAC3 HES1 NOS3 HDAC5 GPT	4.11e-05	61	185	5	DOID:3021 (biomarker_via_orthology)
Disease	pulmonary hypertension (is_marker_for)	HDAC3 NOS3 HDAC5 THBD EGR1	5.19e-05	64	185	5	DOID:6432 (is_marker_for)
Disease	killer cell immunoglobulin-like receptor 2DS2 measurement	KIR2DL1 KIR2DL3 KIR2DL4	1.04e-04	15	185	3	EFO_0801746
Disease	level of killer cell immunoglobulin-like receptor 2DS2 in blood serum	KIR2DL1 KIR2DL3	1.17e-04	3	185	2	OBA_2042107
Disease	nephritis (is_implicated_in)	NOS3 FOXC2	3.86e-04	5	185	2	DOID:10952 (is_implicated_in)
Disease	lung non-small cell carcinoma (is_marker_for)	KDM3B FAP FGF9 IRS4 THBD EGR1	7.12e-04	169	185	6	DOID:3908 (is_marker_for)
Disease	Amelogenesis imperfecta local hypoplastic form	LAMA3 ACP4	8.04e-04	7	185	2	C0399367
Disease	Intrahepatic Cholestasis	ATP8B1 EGR1	8.04e-04	7	185	2	C0008372
Disease	cortical surface area measurement	SOX5 HDAC9 IQGAP2 NPAS3 ADGRV1 SVEP1 PGM1 TYR ZNF469 MAST4 PRRC2C PKD1 EXOC6B CACNA1A DNAJC13 KIF26B KIAA1755 PCDH7 SNTB1	8.35e-04	1345	185	19	EFO_0010736
Disease	diet measurement	SOX5 HDAC9 NPAS3 KDM3B TYR ZNF469 MUC17 EXOC6B KIF26B GRK6 EGR2 RBM6 MBD5 CNOT1 PCDH7 PCK1	9.85e-04	1049	185	16	EFO_0008111
Disease	Alzheimer disease	ABCA7 NOS3	1.07e-03	8	185	2	cv:C0002395
Disease	cerebellar ataxia (implicated_via_orthology)	VPS13A CACNA1A	1.07e-03	8	185	2	DOID:0050753 (implicated_via_orthology)
Disease	Hypoxemia	NOS3 EGR1 PCK2	1.15e-03	33	185	3	C0700292
Disease	Hypoxia	NOS3 EGR1 PCK2	1.15e-03	33	185	3	C0242184
Disease	Anoxemia	NOS3 EGR1 PCK2	1.15e-03	33	185	3	C0003129
Disease	Anoxia	NOS3 EGR1 PCK2	1.15e-03	33	185	3	C0003130
Disease	migraine (is_implicated_in)	NOS3 CACNA1A	1.37e-03	9	185	2	DOID:6364 (is_implicated_in)
Disease	Hepatic Insufficiency	KEAP1 NOS3	1.37e-03	9	185	2	C1306571
Disease	creatinine measurement	SOX5 ADGRV1 FAP PRRC2C EXOG CFAP70 PLIN4 DNAJC13 KIF26B GRK6 PRR22 KIAA1755 MBD5 PCK1 UNC80	1.59e-03	995	185	15	EFO_0004518
Disease	abdominal fat cell number	MAST4 FLNC DNAJC13 POU4F3 XIRP2 KNDC1	1.61e-03	198	185	6	EFO_0021534
Disease	pulmonary hypertension (biomarker_via_orthology)	NOS3 HDAC5 HYAL1 EGR1	1.63e-03	80	185	4	DOID:6432 (biomarker_via_orthology)
Disease	Colorectal Carcinoma	CLSTN3 ABCA1 ABCA4 MFF PGM1 PAX8 ODAM VPS13A FLNC IRS4 DCHS1 ZMYM4	1.67e-03	702	185	12	C0009402
Disease	Cleft Palate	PGM1 FGF9 NOS3 FOXC2	1.71e-03	81	185	4	C0008925
Disease	heart disease (implicated_via_orthology)	SOX5 SOX6 CNOT1	1.74e-03	38	185	3	DOID:114 (implicated_via_orthology)
Disease	cortical thickness	SOX5 HDAC9 ABCA4 ASIC2 PDHB ADGRV1 PGM1 ZNF469 MAST4 PKD1 FOXC2 HSPG2 RAB44 KIAA1755 PCDH7 SNTB1	1.81e-03	1113	185	16	EFO_0004840
Disease	Cleft upper lip	ABCA4 FGF9 NOS3	1.88e-03	39	185	3	C0008924
Disease	obsolete_red blood cell distribution width	ABCA7 PIK3IP1 MAST4 MUC17 PRRC2C NUP210 VPS13A RNF10 TRAPPC9 SOX6 DNAJC13 ASAH2 SH3GL1 HIP1R SCAMP2 POU4F3 RBM6 MAST1	2.11e-03	1347	185	18	EFO_0005192
Disease	S-6-hydroxywarfarin to S-warfarin ratio measurement	CPNE2 ASIC2 KIF26B PCK1	2.31e-03	88	185	4	EFO_0803332
Disease	high grade glioma (is_implicated_in)	SOX6 SH3GL1 ENTPD2	2.33e-03	42	185	3	DOID:3070 (is_implicated_in)
Disease	Secondary Biliary Cholangitis	KEAP1 NOS3 ENTPD2	2.33e-03	42	185	3	C0238065
Disease	Biliary cirrhosis	KEAP1 NOS3 ENTPD2	2.33e-03	42	185	3	C0023892
Disease	Biliary Cirrhosis, Primary, 1	KEAP1 NOS3 ENTPD2	2.33e-03	42	185	3	C4551595
Disease	high grade glioma (is_marker_for)	HDAC3 NOS3 SH3GL1	2.33e-03	42	185	3	DOID:3070 (is_marker_for)
Disease	Reperfusion Injury	TICAM1 NOS3 GPT EGR1	2.41e-03	89	185	4	C0035126
Disease	killer cell immunoglobulin-like receptor 2DL4 measurement	KIR2DL4 KIR2DS4	2.48e-03	12	185	2	EFO_0008197
Disease	right ventricular stroke volume measurement	NOS3 KIAA1755	2.48e-03	12	185	2	EFO_0021817
Disease	brain disease (is_implicated_in)	TICAM1 MFF	2.48e-03	12	185	2	DOID:936 (is_implicated_in)
Disease	lymphangioleiomyomatosis (is_marker_for)	ACSS2 NOS3	2.48e-03	12	185	2	DOID:3319 (is_marker_for)
Disease	middle cerebral artery infarction (biomarker_via_orthology)	HDAC9 HDAC5 EGR1 EGR2	2.83e-03	93	185	4	DOID:3525 (biomarker_via_orthology)
Disease	Connective Tissue Diseases	ZNF469 PKD1	2.91e-03	13	185	2	C0009782
Disease	Paroxysmal atrial fibrillation	SOX5 NOS3 HSPG2 HIP1R MBD5	3.09e-03	156	185	5	C0235480
Disease	familial atrial fibrillation	SOX5 NOS3 HSPG2 HIP1R MBD5	3.09e-03	156	185	5	C3468561
Disease	Persistent atrial fibrillation	SOX5 NOS3 HSPG2 HIP1R MBD5	3.09e-03	156	185	5	C2585653
Disease	colorectal cancer (is_marker_for)	ADGRB1 KDM3B HDAC3 IRS4 HDAC5	3.18e-03	157	185	5	DOID:9256 (is_marker_for)
Disease	Primary biliary cirrhosis	KEAP1 NOS3 ENTPD2	3.21e-03	47	185	3	C0008312
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD1 FLNC	3.39e-03	14	185	2	DOID:898 (implicated_via_orthology)
Disease	thalamus volume change measurement	ASIC2 KIF26B	3.39e-03	14	185	2	EFO_0021496
Disease	pimelic acid measurement, 3-methyladipic acid measurement	ABCA1 SNTB1	3.39e-03	14	185	2	EFO_0010449, EFO_0010524
Disease	pulmonary emphysema (is_marker_for)	KEAP1 EGR1	3.39e-03	14	185	2	DOID:9675 (is_marker_for)
Disease	Atrial Fibrillation	SOX5 NOS3 HSPG2 HIP1R MBD5	3.44e-03	160	185	5	C0004238
Disease	Vitiligo	TICAM1 ATP8B1 TYR FAP	3.81e-03	101	185	4	EFO_0004208
Disease	mouth morphology measurement	HDAC9 OXR1 PCDH7	3.83e-03	50	185	3	EFO_0007955
Disease	Schizophrenia	SOX5 HDAC9 ABCA1 NPAS3 CMYA5 TYR HDAC3 PML GRK6 RANBP9 EGR2 PCDH8 PCK1	3.93e-03	883	185	13	C0036341
Disease	waist-hip ratio	ABCA1 NAGLU ITGA7 RNF157 CUEDC1 MAST4 PKD1 PML PLIN4 COL6A2 IQCH HIP1R RBM6 SNTB1 PCK1 ZMYM4	4.64e-03	1226	185	16	EFO_0004343
Disease	pathological myopia	ABCA1 PML PGBD2 SNTB1	5.32e-03	111	185	4	EFO_0004207
Disease	familial hyperlipidemia (biomarker_via_orthology)	ABCA1 NOS3	6.23e-03	19	185	2	DOID:1168 (biomarker_via_orthology)
Disease	emphysema pattern measurement	VWA8 TRAPPC9	6.23e-03	19	185	2	EFO_0005850
Disease	facial asymmetry measurement	SOX5 NPAS3	6.23e-03	19	185	2	EFO_0009751
Disease	insulin sensitivity measurement, body mass index	NPAS3 FGF9	6.23e-03	19	185	2	EFO_0004340, EFO_0004471

Protein segments in the cluster

Peptide	Gene	Start	Entry
GIPADPNNVFLSTGA	GPT	146	P24298
GGQFNFDEGTPPTNF	CACNA1A	636	O00555
LHFPGDVFAAPEQVG	DISP3	641	Q9P2K9
DVFAAPEQVGGSPAQ	DISP3	646	Q9P2K9
FNPTNPFCSGVDGIA	CPNE2	381	Q96FN4
FARPAVDFEGTNGVP	CLSTN3	651	Q9BQT9
DLNPVEQFFQGNFPG	ABCA4	2181	P78363
EELGDELQQFGFPAP	ADGRB1	336	O14514
ELQQFGFPAPQTGDP	ADGRB1	341	O14514
FAGDDAPQAVFPSIV	POTEKP	21	Q9BYX7
FGVQDAVPFGNVPVL	FGF9	11	P31371
AGSNPDLKPVQDFFG	ABCA1	2146	O95477
GFNSKAVTPDDIGPF	ADGRV1	696	Q8WXG9
TVVIPQNDSPFGVFG	ADGRV1	4021	Q8WXG9
GDPNGVVQFAPETLS	ADGRV1	4636	Q8WXG9
LDNVDPNPENFVGAG	AP2A1	916	O95782
QEALDPGPFDQGSPF	ELF3	151	P78545
FPFFGVAPAILNESG	ACSS2	491	Q9NR19
EPTPASFFIGDQNGD	CEP170B	791	Q9Y4F5
AVGEGPLNEFAFSPD	DMWD	281	Q09019
VQESFFPPGGNRALI	ATP8B1	786	O43520
SQPAAAFVAAEFPGA	ABCA7	2031	Q8IZY2
EAVNGGPEAARLFPN	NAGLU	421	P54802
APLAPGSEDNFARFV	AP2A2	696	O94973
QSEPPFIQELGFGVA	ASIC2	251	Q16515
FNISNGGPAPEAITD	PGM1	131	P36871
PGEVVDANFGQHPFV	RANBP9	321	Q96S59
DLQQVGSGVPPFNAF	PAX8	331	Q06710
FTVEPVPEGAQLSFG	HSPG2	1371	P98160
INPENGFFGVAPGTS	PCK1	326	P35558
QAFLFGQEPSSDPDG	RAB44	416	Q7Z6P3
NNDGGIFDDPPALSE	RAD21	236	O60216
VTIFPNAELGGPFDQ	EGR2	36	P11161
GPPGEEAQVASQFIA	EXOSC8	96	Q96B26
FLSQGGVIEAFPPAD	IQCH	736	Q86VS3
KVNGTFQADFPLGPA	KIR2DS2	176	P43631
GVFSAGLAPAAFVPN	PUM2	296	Q8TB72
SVNGTFQADFPLGPA	KIR2DL5A	171	Q8N109
NPFGPGQFFDLSIRC	LGALS4	266	P56470
FNVANGGPAPDVVSD	PGM5	136	Q15124
NPFEDVPVVNGTSFD	ANKFY1	421	Q9P2R3
EGVSAFFGVTVQDPP	OBSL1	791	O75147
PEAFDPDVGVNSLQG	PCDHGA4	186	Q9Y5G9
PAAGLGVEFEAPQEA	PODXL2	271	Q9NZ53
VGAEVPFSPGLFADQ	NUP210	1681	Q8TEM1
EGPAFNFLDAPAVRV	PDHB	311	P11177
FLAVAENQPPGTSVG	DCHS1	1111	Q96JQ0
KVNGTFQADFPLGPA	KIR2DL2	176	P43627
SINGTFQADFPLGPA	KIR2DS4	176	P43632
AFVTVPGNGFADPFS	LAMA3	826	Q16787
FSTCLEGEQGPQFAP	GPR176	406	Q14439
APPNADLEQGFQEGV	MFF	56	Q9GZY8
KVNGTFQADFPLGPA	KIR2DL3	176	P43628
FQAGSPPQEAGQAAE	KIAA1755	1121	Q5JYT7
PGQGPFVAAFASSNL	ASAH2	336	Q9NR71
PGPQAVQIHFAAGDF	ASMTL	496	O95671
GLSGFLPDPFFQVQV	CD300H	121	A0A0K2S4Q6
PFEELPAQFGPEQAS	KIF26B	946	Q2KJY2
IFPEPQSQAFPGSAG	EGR1	216	P18146
NGVFQPPVAGNFVAF	ENTPD2	331	Q9Y5L3
SVDGTFQADFPLGPA	KIR2DL5B	171	Q8NHK3
AGFHPPIDDVQGSFQ	PCYOX1L	316	Q8NBM8
LRAINPENGFFGVAP	PCK2	341	Q16822
AEFQDIPSFPAQPQG	PNMA6F	96	A0A0J9YX94
VGPFQEAAFALPVSG	PIN4	91	Q9Y237
QYDGESPGAFPVAAQ	PLXNB1	1476	O43157
VQDLPPANTFVGAGD	PCDH7	1021	O60245
ADPDEGPNGDVVFAF	PCDH8	271	O95206
EGPSPQFTLDFGNDA	PDCD2L	136	Q9BRP1
VAVGNDFGFSSPVPG	CUEDC1	276	Q9NWM3
TQVGGDPFPAVFGDF	FLNC	2211	Q14315
EPAISGGQQQLAFDP	ODAM	191	A1E959
QAGLDFSQPFPSGEF	DEFB105A	26	Q8NG35
FLGDAVFIPAGAPHQ	KDM3B	1676	Q7LBC6
KVNGTFQADFPLGPA	KIR2DS3	176	Q14952
FQADFPLGPATQGGT	KIR2DS3	181	Q14952
NGFCEQLNEDFEGPP	GGA1	31	Q9UJY5
LGAFVVPNEAIGFQP	EXOG	246	Q9Y2C4
AAAPNGLPGFSVENI	FOXC2	261	Q99958
AGFPQGLVNLSDPAA	AMH	321	P03971
AVFAIPAANRPGFTG	KIAA1549L	1711	Q6ZVL6
PGVLAGQPFFDAIFT	QPRT	51	Q15274
CEQFARSGPVPGFQE	EXOC6B	706	Q9Y2D4
EGPGADEVQVFAPAN	PIK3IP1	121	Q96FE7
SFGNLEVSPPVVANG	PADI3	406	Q9ULW8
NGIFLPPLQGDFGAF	ENTPD1	346	P49961
NGQEIPADTLGQFPS	GOLGA3	346	Q08378
AFQGTPLAQAVEGPS	UQCRC1	191	P31930
VPNVVAGFRNPDGFV	DXO	286	O77932
NAFNVGDDCPVFPGL	HDAC3	86	O15379
NFFPPGNEVVNGENL	MEDAG	176	Q5VYS4
PFFGDTPEELFGQVI	MAST1	586	Q9Y2H9
NGDPPENGESFAAAL	NOS3	576	P29474
VPSINGTFQADFPLG	KIR2DL4	171	Q99706
AQANLAGLFPEAAPG	ACP4	116	Q9BZG2
SVDINAPGFNPLAGA	OXR1	16	Q8N573
SGPAQNPGIDFDIEE	ATMIN	626	O43313
LPGNGADLFQVDPVS	CDHR2	521	Q9BYE9
LFDQTFGPPNGSVKD	HIP1R	336	O75146
QGFSLFPVIGAPAQN	IL1RL1	206	Q01638
FEVRFDPQGANLPVG	HYDIN	1656	Q4G0P3
NDFDFGVGPKTPNAV	CRISP3	121	P54108
PDDIFFNLGDPQNGR	DENND2A	461	Q9ULE3
NGDPFFPGSQLVVTQ	DCDC2B	16	A2VCK2
GPPLGAENFTVTVAN	FCGBP	4506	Q9Y6R7
LAPGANNIPDAFIVG	CFAP70	236	Q5T0N1
ASGAGPADQLALFPQ	B3GALNT2	31	Q8NCR0
SVAEGGNPEEFQPFT	CMYA5	1731	Q8N3K9
GNPEEFQPFTFSLKG	CMYA5	1736	Q8N3K9
QAPGRVAFVSEPGAF	JMJD4	71	Q9H9V9
QFGGPGEQQVAFPLS	COL6A2	881	P12110
ILPGPNEEFGILFAN	FSCN3	371	Q9NQT6
APAQFEGTEQAPFLG	DIDO1	1866	Q9BTC0
FLATPPNGNFADAVF	DNAJC13	361	O75165
GGFPNSVIAEFSEEP	FAM169A	541	Q9Y6X4
ETPLAPFPNGSFVNG	LARP4	336	Q71RC2
VPFFGDTPEELFGQV	MAST4	781	O15021
SQLPIGSDFPFVGQE	MBD5	881	Q9P267
PENGPPFQFFLDNSA	DSC1	601	Q08554
FTEDPGAFPVATNGE	ERAP2	46	Q6P179
FLPLQSQCPEGAGDA	KEAP1	16	Q14145
GGTAQFQAKELQPFP	KLHDC7B	556	Q96G42
AEDGAVLFQPPPANG	KNDC1	491	Q76NI1
PVPVAQENQGVFFSG	CAPG	31	P40121
FDVVANPGQTFRGPD	HYAL1	56	Q12794
FGAENPDPFVPVLNT	HEATR1	1681	Q9H583
NQDGFPDIAVGAPFD	ITGA7	436	Q13683
DNAVPGAPSFQDPAI	HOMEZ	421	Q8IX15
DNGNFFPGSGAPEEV	HDAC5	896	Q9UQL6
DEGNFFPGSGAPNEV	HDAC9	846	Q9UKV0
DEFSELFGPHQQGLP	GLIS1	151	Q8NBF1
FQELNVFGLDGSVPP	GRK6	521	P43250
PFGVQLPGAQQSSFD	B3GNT6	331	Q6ZMB0
LPAGPKVNGTFQADF	KIR2DL1	171	P43626
KVNGTFQADFPLGPA	KIR2DL1	176	P43626
VGSEPQAFDVFPENP	PRRT3	51	Q5FWE3
EPVDFQPQAGFAAEG	CZIB	106	Q9NWV4
PGFIQFLGETQFAPG	CLIP1	71	P30622
TFGDGEQALHQFQPP	PKD1	1056	P98161
PSIEVFQPSNKEGFG	PARP6	111	Q2NL67
PSGEIENQAVPAFQG	PAGE2	51	Q7Z2X7
NGNTQDDFLSPVGVP	OTOG	656	Q6ZRI0
FGGFQVVPAPDGQFA	HES1	216	Q14469
NVEFGVPFPNPANDL	IRS4	961	O14654
KVNGTFQANFPLGPA	KIR2DS1	176	Q14954
EDSGPAPGTFQNIGF	MUC17	4436	Q685J3
FGASLLPQGFDFQAP	FOXF2	216	Q12947
NGGEQTALSPQEAPF	PLIN4	1061	Q96Q06
DFQGHSGPPFANVEE	RBM6	56	P78332
NGFSITTEPQEGAFP	SNTB1	461	Q13884
PFAARGADFQALPVG	THBD	196	P07204
ESPDSNFAGLPAGEQ	RNF157	571	Q96PX1
FQGGTLAQDDPPIIF	TAPBPL	81	Q9BX59
GEDTIRQAFAPFGPI	PUF60	141	Q9UHX1
ESFLGEGAVDPNDPN	IQGAP2	1251	Q13576
GPGLPNFFRALEDIN	PML	681	P29590
FGAPASNGNENEVVP	PRRC2C	2056	Q9Y520
LTNAPQGGLAEFNPF	SCAMP2	26	O15127
VNFVDVNSPGFGLDP	NPAS3	851	Q8IXF0
LRDPPAGVQFNFDFD	SYAP1	151	Q96A49
PAFQQLVNFSEGGPG	ISL1	306	P61371
AAAPPGRFNIENIDG	NOPCHAP1	91	Q8N5I9
FVPAAGDIPGNTQES	PPP1R15B	346	Q5SWA1
LPAPQLQGNIFGSFD	POU4F3	36	Q15319
LFCDPGFQLVGNPVQ	SVEP1	1656	Q4LDE5
GEDGFQGTAPVDAFP	SUMF1	271	Q8NBK3
AAAAAQQGFLFPPGI	SOX6	281	P35712
SQDEPPFIDQLGFGV	ASIC1	251	P78348
PFIDQLGFGVAPGFQ	ASIC1	256	P78348
TGALGLPAVNNDPFV	CNOT1	791	A5YKK6
EIFIAPPDNAAGEFT	PGBD2	41	Q6P3X8
AVTGPLFDFQGDPAQ	PRXL2C	161	Q7RTV5
PGDPPFQITFNGREN	FAP	176	Q12884
FEATAGPNKPESGFA	XIRP2	11	A4UGR9
AAPQEGFSPQSLEGA	PRR22	11	Q8IZ63
TNFFRGALQPQPEGA	TBC1D17	231	Q9HA65
EPFDLGEPEQSNGGF	SH3GL1	261	Q99961
GAGPSALFENVPQEA	ZNF653	286	Q96CK0
PQSPVSENVFVADFG	VPS13A	1221	Q96RL7
LEFPDAANNGPSKGV	UNC80	2281	Q8N2C7
AGNGAPFEESLAPLQ	STAT6	211	P42226
VPDGATFCEDFQVPG	TICAM1	421	Q8IUC6
EAQRAEFSPAQFSGP	RNF10	121	Q8N5U6
SNAPLGPQFPFTGVD	TYR	61	P14679
EGATGPFLEPSQQQA	PPP1R3F	441	Q6ZSY5
PPAAENSFPGANFGV	ZNF469	236	Q96JG9
SQQGLFPGEDLGDPF	ZNF70	21	Q9UC06
QAIFNPDTPFGDIVG	TTC36	11	A6NLP5
AQQSFEPAGLPQGFT	ZNF236	871	Q9UL36
GPPDNFAVGPVNQFD	PNISR	151	Q8TF01
AAAAQQGFLLPPGFS	SOX5	291	P35711
NFESFPESPGEKGQF	TRAPPC9	946	Q96Q05
RFFVGPEDTEINPGN	PPIP5K2	6	O43314
PVLFQSPRGFEAGFE	ZSCAN29	556	Q8IWY8
VLANRPGFPFLGNDF	VWA8	901	A3KMH1
FASGDQVFQVPIQGP	MST1R	511	Q04912
VFGGDVNPPFDQLCS	TCTN2	206	Q96GX1
ASVFGASGLDNQPPE	USP13	716	Q92995
DFPSDSFDPLNKGQG	ZMYM4	1141	Q5VZL5
ISPQDFPQNPGFGDV	ZNF7	111	P17097
FPQNPGFGDVSDSEV	ZNF7	116	P17097
EIGLGTPPQNFTVAF	NAPSA	81	O96009
ELFAQAPVDQFPGTA	NECAP2	66	Q9NVZ3